Biodesix, Inc.

NASDAQ:BDSX

0.7221 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q22018 Q1
Revenue 20.42918.15117.92514.81814.66813.49111.8729.0569.60811.10710.956.5487.2246.53111.88528.86627.0289.1934.2395.0968.2713.9426.176.175.1085.108
Cost of Revenue 4.3424.1793.8773.1753.3743.2293.2383.1693.3063.6333.983.2352.4932.7227.08518.21814.6523.8911.8741.5811.831.5031.3711.3711.1021.102
Gross Profit 16.08713.97214.04811.64311.29410.2628.6345.8876.3027.4746.973.3134.7313.8094.810.64812.3765.3022.3653.5156.4412.4394.7994.7994.0074.007
Gross Profit Ratio 0.7870.770.7840.7860.770.7610.7270.650.6560.6730.6370.5060.6550.5830.4040.3690.4580.5770.5580.690.7790.6190.7780.7780.7840.784
Reseach & Development Expenses 2.4142.5472.5582.041.8891.9382.913.2513.5652.973.3613.2062.8523.2933.3233.3213.1052.7062.1072.92.5022.3592.8042.8042.0472.047
General & Administrative Expenses 000035.240000000000026.9787.87900000000
Selling & Marketing Expenses 0000-18.9890018.98916.62615.11415.23514.48713.55813.60711.42511.92712.0647.8796.8348.086.5578.212006.4756.475
SG&A 20.21920.01619.6620.55616.25115.49616.65118.98916.62615.11415.23514.48713.55813.60711.42511.92712.0647.8796.8348.086.5578.2127.9347.9346.4756.475
Other Expenses 0.1030-0.387-0.0640.0020.0020.0010.001-0.0050.0020.10.012-0.012.722-0.6390.0010.036-0.9040.1330.123-0.855-0.7630000
Operating Expenses 22.73622.56322.21822.59618.1417.43419.56122.2420.19118.08418.59617.69316.4116.914.74815.24815.16910.5858.94110.989.05910.57111.44911.4498.5228.522
Operating Income -6.649-8.591-8.17-10.953-6.846-7.172-10.927-16.353-13.889-10.61-11.626-14.38-11.679-13.091-10.587-5.583-2.655-6.24-5.619-8.422-3.544-9.028-5.939-5.939-4.515-4.515
Operating Income Ratio -0.325-0.473-0.456-0.739-0.467-0.532-0.92-1.806-1.446-0.955-1.062-2.196-1.617-2.004-0.891-0.193-0.098-0.679-1.326-1.653-0.428-2.29-0.963-0.963-0.884-0.884
Total Other Income Expenses Net -1.602-1.667-2.571-2.593-2.293-3.777-2.429-2.329-6.448-3.089-4.198-1.125-1.6031.577-0.815-1.378-1.88-2.605-2.647-1.283-2.981-0.573-1.361-1.361-2.026-2.026
Income Before Tax -8.251-10.258-10.808-13.614-9.139-10.949-13.356-18.702-20.337-13.699-15.824-15.586-13.282-11.514-11.402-6.961-4.535-8.845-8.266-9.705-6.525-9.601-7.3-7.3-6.542-6.542
Income Before Tax Ratio -0.404-0.565-0.603-0.919-0.623-0.812-1.125-2.065-2.117-1.233-1.445-2.38-1.839-1.763-0.959-0.241-0.168-0.962-1.95-1.904-0.789-2.436-1.183-1.183-1.281-1.281
Income Tax Expense 0001.279-3.2312.3862.431-1.5866.4493.0891.4461.206-7.521.5460.8150.6520.0121.7542.9171.580.148-0.05700-1.297-1.297
Net Income -8.251-10.258-10.808-13.614-9.139-10.949-13.356-17.116-26.786-16.788-15.824-16.792-13.282-11.514-11.402-6.961-4.535-8.845-8.266-9.705-6.525-9.601-7.3-7.3-6.542-6.542
Net Income Ratio -0.404-0.565-0.603-0.919-0.623-0.812-1.125-1.89-2.788-1.511-1.445-2.564-1.839-1.763-0.959-0.241-0.168-0.962-1.95-1.904-0.789-2.436-1.183-1.183-1.281-1.281
EPS -0.064-0.07-0.085-0.14-0.099-0.14-0.17-0.22-0.46-0.42-0.4-0.54-0.49-0.41-0.41-0.26-0.17-0.33-0.31-0.37-0.25-0.362-0.32-0.32-0.25-0.25
EPS Diluted -0.064-0.07-0.085-0.14-0.099-0.14-0.17-0.22-0.46-0.42-0.4-0.54-0.49-0.41-0.41-0.26-0.17-0.33-0.31-0.37-0.25-0.362-0.32-0.32-0.25-0.25
EBITDA -5.101-6.8-7.553-9.763-5.505-7.324-9.508-15.526-16.889-9.767-13.58-13.541-10.931-9.168-9.864-5.583-3.099-5.404-4.769-7.57-5.472-8.197-5.248-5.248-5.378-5.378
EBITDA Ratio -0.25-0.375-0.382-0.65-0.378-0.531-0.801-1.806-1.446-0.805-0.93-2.013-1.618-1.882-0.772-0.133-0.102-0.588-1.352-1.308-0.327-2.079-0.851-0.851-1.053-1.053